Terms: = Thyroid cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
60 results:
1. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/hmga2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract] [Full Text] [Related]
2. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
Liu Y; Chen K; Shou Y; Li S; Wang J; Zhang Q; Huang Z; Xu J; Li M; Liu D; Liang H; Yang H; Zhang X
Clin Transl Med; 2023 Dec; 13(12):e1512. PubMed ID: 38073586
[TBL] [Abstract] [Full Text] [Related]
3. LINC02454 promotes thyroid carcinoma progression via upregulating hmga2 through CREB1.
Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
[TBL] [Abstract] [Full Text] [Related]
4. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells.
Jin S; Yong H; Liu Y; Bao W
Adv Med Sci; 2023 Sep; 68(2):409-416. PubMed ID: 37837800
[TBL] [Abstract] [Full Text] [Related]
5. C2orf48 promotes the progression of nasopharyngeal carcinoma by regulating high mobility group AT-hook 2.
Jiang Y; Liang F; Chen R; Huang Y; Xiao Z; Zeng H; Han P; Huang X
Med Oncol; 2023 Sep; 40(11):306. PubMed ID: 37755629
[TBL] [Abstract] [Full Text] [Related]
6. Unraveling the Roles of miR-204-5p and hmga2 in Papillary thyroid cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract] [Full Text] [Related]
7. [circ_0092315 Promotes Proliferation and Invasion of Papillary thyroid Carcinoma Cells
Ke SH; Kong CX; Xu Y; Peng C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):16-21. PubMed ID: 36861149
[TBL] [Abstract] [Full Text] [Related]
8. Has_circ_0048764 promotes breast cancer progression by sponging miR-578 and regulating hmga2 expression.
Ding M; Dai D; Yang W; Geng C; Cui G
Nucleosides Nucleotides Nucleic Acids; 2023; 42(6):448-463. PubMed ID: 36617513
[TBL] [Abstract] [Full Text] [Related]
9. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
[TBL] [Abstract] [Full Text] [Related]
10. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract] [Full Text] [Related]
11. Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens.
Wang Y; McKelvey BA; Liu Z; Rooper L; Cope LM; Zeiger MA; Umbricht CB
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2983-2991. PubMed ID: 34165589
[TBL] [Abstract] [Full Text] [Related]
12. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract] [Full Text] [Related]
13. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract] [Full Text] [Related]
14. Long Noncoding RNA LINC02163 Accelerates Malignant Tumor Behaviors in Breast cancer by Regulating the MicroRNA-511-3p/hmga2 Axis.
Qin C; Jin L; Li J; Zha W; Ding H; Liu X; Zhu X
Oncol Res; 2020 Dec; 28(5):483-495. PubMed ID: 32571448
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/hmga2 axis.
Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
[TBL] [Abstract] [Full Text] [Related]
17. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating hmga2 expression.
Cai X; Nie J; Chen L; Yu F
Mol Genet Genomic Med; 2020 Feb; 8(2):e1093. PubMed ID: 31845519
[TBL] [Abstract] [Full Text] [Related]
18. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by hmga2.
Qiu K; Xie Q; Jiang S; Lin T
J Clin Lab Anal; 2020 Feb; 34(2):e23044. PubMed ID: 31670857
[TBL] [Abstract] [Full Text] [Related]
19. Combined quantitation of hmga2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
Titov SE; Ivanov MK; Demenkov PS; Katanyan GA; Kozorezova ES; Malek AV; Veryaskina YA; Zhimulev IF
BMC Cancer; 2019 Oct; 19(1):1010. PubMed ID: 31660895
[TBL] [Abstract] [Full Text] [Related]
20. Proteomic analysis of the papillary thyroid microcarcinoma.
Jin S; Bao W; Yang YT; Fu Q; Bai Y; Liu Y
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):293-300. PubMed ID: 31606199
[TBL] [Abstract] [Full Text] [Related]
[Next]
